#gip

1 story

#clinical trial #eli lilly #glp-1 #glucagon #obesity treatment #retatrutide #science #technology #weight loss

Obesity drug cuts weight by 25 percent in trial
Retatrutide, a triple-acting hormone treatment from Eli Lilly, showed the strongest weight loss results yet in late-stage testing.
Ars Technica · 2m